查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1499422

全球肠道疾病检测市场：按产品、疾病类型、诊断技术和检测地点 - 预测（2024-2030）

Enteric Disease Testing Market by Product (Consumables, Kits, Reagents), Disease Type (Bacterial, Parasitic, Viral), Diagnostic Techniques, Testing Site - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年全球肠道疾病检测市场规模为43.1亿美元，2024年达45.4亿美元，2030年达62.6亿美元，复合年增长率为5.47%。

肠道疾病检测包括各种诊断程序，旨在识别影响胃肠道感染的感染疾病。随着肠道疾病的全球流行、诊断技术、意识和医疗保健支出的进步，对肠道疾病检测的需求持续增长，因为早期和准确的诊断在管理和预防此类疾病的传播方面发挥关键作用。然而，他们面临着挑战​​，例如与先进测试技术相关的高成本、资源匮乏环境中的访问受限以及需要熟练人员来执行和解释测试。为了解决这些问题，人们持续专注于开发具有成本效益且易于使用的诊断解决方案，这些解决方案可以广泛部署，包括在资源有限的环境中。分子诊断、就地检验以及人工智慧和机器学习的应用相结合，提高检测的准确性和速度，预计将使检测程式多样化。

主要市场统计
基准年[2023] 43.1亿美元
预计年份 [2024] 45.4亿美元
预测年份 [2030] 62.6亿美元
复合年增长率（%） 5.47%

区域洞察

在强大的医疗保健系统和高昂的医疗成本的推动下，美洲，特别是美国和加拿大，先进诊断解决方案的采用率很高，包括分子诊断和就地检验。该地区的公司享有有利的法规环境和大量的研发投资，使他们能够快速创新并生产肠道疾病检测解决方案。在亚太地区，由于人们对霍乱和伤寒等疾病的认识不断提高以及医疗费用不断上涨，对肠道疾病诊断的需求不断增加。然而，这个市场的特点是先进和传统诊断方法的混合，并且各国之间的医疗基础设施存在显着差异。亚太地区的生产正在扩大，当地企业与成熟的全球企业一起崛起。欧洲、中东和非洲是多样化的，西欧市场高度发达，采用了尖端的诊断技术，而非洲和中东的一些国家获得肠道疾病检测的机会有限，我们正在解决与采购和检测相关的问题。方便。欧洲、中东和非洲的法规环境差异很大，影响了新技术的采用速度。在欧洲、中东和非洲运营的公司平衡技术创新和具有成本效益的生产，以满足不同患者群体的需求。

FPNV定位矩阵

FPNV定位矩阵对于评估供应商在肠道疾病检测市场的定位至关重要。此矩阵提供了对供应商的全面评估，并检查了与商务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果，供应商被分为代表其成功程度的四个像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对肠道疾病检测市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献，您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他关键指标。此外，该分析还提供了对该领域竞争性质的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息，供应商可以做出更明智的决策并製定有效的策略，以在市场竞争中保持领先地位。

策略分析与建议

策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对当前肠道疾病检测市场地位的全面评估使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析，以确定核心优势和需要改进的领域。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 由于卫生条件不佳和供水受污染而导致肠道疾病传播
      • 诊断测试的技术创新提高了灵敏度、特异性并更快获得结果。
      • 政府和非政府组织为对抗感染疾病所做的努力
    • 抑制因素
      • 新兴国家先进测试高成本且基础设施缺乏
    • 机会
      • 增加对医疗基础设施的投资并专注于预防性诊断
      • 研发活动和市场拓展的策略伙伴关係和合作
    • 任务
      • 产品核准和商业化规定
  • 市场区隔分析
    • 疾病类型：在细菌检测中更多地采用多重和分子诊断方法
    • 测试地点：快速诊断对于医院即时患者照护至关重要
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章肠道疾病检测市场：副产品

  • 消耗品
  • 套件
  • 试剂

第七章肠道疾病检测市场：依疾病类型

  • 细菌
  • 寄生虫
  • 病毒性的

第八章肠道疾病检测市场：透过诊断技术

  • 免疫学测试
  • 分子诊断
  • 快速诊断

第九章肠道疾病检测市场：依检测地点

  • 医院
  • 照护现场
  • 独立实验室

第十章美洲肠道疾病检验市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太肠道疾病检验市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东、非洲肠道疾病检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 市场占有率分析（2023）
  • FPNV定位矩阵（2023）
  • 竞争情境分析
    • FDA核准MeMed BV Direct 从全血中提取
    • Avacta 收购欧洲诊断测试製造商
    • 默克透过收购 Prometheus Biosciences 加强免疫学产品线
  • 战略分析和建议

第14章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-732E7CFCB4A5

[198 Pages Report] The Enteric Disease Testing Market size was estimated at USD 4.31 billion in 2023 and expected to reach USD 4.54 billion in 2024, at a CAGR 5.47% to reach USD 6.26 billion by 2030.

Enteric disease testing encompasses a variety of diagnostic procedures aimed at identifying pathogens that cause infectious diseases affecting the gastrointestinal tract. Given the critical role of early and accurate diagnosis in managing and preventing the spread of these diseases, the need for enteric disease testing is driven by factors such as the growing global prevalence of enteric diseases, advancements in diagnostic technologies, and increased awareness and healthcare spending. However, the practice faces challenges such as the high costs associated with advanced testing technologies, limited accessibility in low-resource settings, and the need for skilled personnel to conduct and interpret tests. To address these issues, there is an ongoing focus on developing cost-effective and user-friendly diagnostic solutions that can be deployed widely, including in resource-constrained environments. The integration of molecular diagnostics, point-of-care testing, and the application of artificial intelligence and machine learning to improve test accuracy and speed is expected to diversify the testing procedures.

KEY MARKET STATISTICS
Base Year [2023] USD 4.31 billion
Estimated Year [2024] USD 4.54 billion
Forecast Year [2030] USD 6.26 billion
CAGR (%) 5.47%

Regional Insights

In the Americas, especially the United States and Canada, there is a high adoption rate of advanced diagnostic solutions, including molecular diagnostics and point-of-care testing, driven by robust healthcare systems and high healthcare expenditure. Companies in this region benefit from a conducive regulatory environment and significant investment in R&D, leading to rapid innovation and production of enteric disease testing solutions. The APAC region has a growing demand for enteric disease diagnostics due to increasing awareness of diseases such as cholera and typhoid coupled with rising healthcare spending. However, the market is characterized by a mix of advanced and traditional diagnostic practices, with significant variations in healthcare infrastructure across countries. Production in APAC is growing, with local companies emerging alongside established global players. EMEA presents a diverse picture, with highly developed markets in Western Europe employing cutting-edge diagnostic technologies while countries in Africa and parts of the Middle East grapple with challenges related to access and affordability of enteric disease testing. Regulatory environments across EMEA vary widely, affecting the pace of adoption of new technologies. Companies operating in EMEA are balancing innovation with cost-effective production to meet the needs of a diverse patient population.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Enteric Disease Testing Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Rising prevalence of enteric diseases due to poor sanitation and contaminated water supplies
      • Technological innovations in diagnostic tests offer greater sensitivity, specificity, and faster results
      • Governmental and non-governmental organizations' initiatives to control infectious diseases
    • Market Restraints
      • High cost of advanced tests and the lack of infrastructure in emerging countries
    • Market Opportunities
      • Increasing investment in healthcare infrastructure and the focus on preventive diagnostics
      • Strategic partnerships and collaborations for R&D activities and market expansion
    • Market Challenges
      • Regulations concerning the approval and commercialization of product
  • Market Segmentation Analysis
    • Disease Type: Increasing preference for multiplex and molecular diagnostic methods for bacterial testing
    • Testing Site: Need for rapid diagnostics crucial for immediate patient care in hospitals
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Enteric Disease Testing Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Enteric Disease Testing Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

FDA Clears MeMed BV Direct from Whole Blood

MeMed announced that its innovative MeMed BV test, designed for rapid differentiation between bacterial and viral infections, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for whole blood samples. This significant milestone allows healthcare professionals to leverage the MeMed Key analyzer, a leading-edge point-of-care device, to diagnose infections accurately in as little as 15 minutes. This breakthrough underscores MeMed's commitment to advancing host response technology and improving patient care by enabling timely and precise treatment decisions. [Published On: 2023-07-19]

Avacta Acquires European Diagnostic Test Maker

Avacta Group, a notable entity in the biotechnology sector, strategically expanded its portfolio by acquiring Coris Bioconcept SRL, a distinguished European producer of rapid diagnostic test kits. Coris Bioconcept specializes in developing, manufacturing, and commercializing lateral flow tests primarily intended for use by healthcare professionals. The company boasts a robust global distribution network, reaching markets across Europe, Asia, South America, Africa, and Oceania, enhancing its presence and operational reach in diagnostic testing. [Published On: 2023-06-01]

Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.

Merck, internationally known as MSD, announced its strategic move to acquire Prometheus Biosciences, Inc., a company in the biotechnological realm focusing on precision medicine methodologies for immune-mediated diseases. This acquisition set the transaction at an impressive total equity value of around USD 10.8 billion. Prometheus, recognized for its innovative approach to developing therapeutic and companion diagnostic solutions, is currently in the clinical stage. This partnership underscores Merck's commitment to advancing healthcare solutions by integrating cutting-edge technology and scientific research into its comprehensive portfolio. [Published On: 2023-04-16]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Enteric Disease Testing Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Enteric Disease Testing Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Als Limited, Asure Quality, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biomerica Inc., bioMerieux SA, Bureau Veritas Group, Cepheid Inc., Coris BioConcept SPRL, DiaSorin, Eurofins Scientific SE, Hardy Diagnostics, Intertek Group PLC, Merck & Co., Inc., Merck KGAA, Meridian Bioscience Inc., Merieux NutriSciences Corporation, Neogen Corporation, Nova Biologicals, Perkinelmer, Inc., Qiagen N.V., Quest Diagnostics, Romer Labs Division Holding GmbH, SGS SA, Symbio Laboratories, Thermo Fisher Scientific Inc., Trinity Biotech PLC, and TUV SUD AG.

Market Segmentation & Coverage

This research report categorizes the Enteric Disease Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Consumables
    • Kits
    • Reagents
  • Disease Type
    • Bacterial
      • Cholera
      • Escherichia coli
      • Salmonellosis
    • Parasitic
    • Viral
  • Diagnostic Techniques
    • Immunoassays
    • Molecular Diagnostics
      • PCR
      • Real-time PCR
    • Rapid Diagnostics
      • Dipsticks
      • Lateral Flow Assays
  • Testing Site
    • In-Hospital
    • Point-of-Care
    • Standalone Laboratories
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of enteric diseases due to poor sanitation and contaminated water supplies
      • 5.1.1.2. Technological innovations in diagnostic tests offer greater sensitivity, specificity, and faster results
      • 5.1.1.3. Governmental and non-governmental organizations' initiatives to control infectious diseases
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of advanced tests and the lack of infrastructure in emerging countries
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing investment in healthcare infrastructure and the focus on preventive diagnostics
      • 5.1.3.2. Strategic partnerships and collaborations for R&D activities and market expansion
    • 5.1.4. Challenges
      • 5.1.4.1. Regulations concerning the approval and commercialization of product
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Disease Type: Increasing preference for multiplex and molecular diagnostic methods for bacterial testing
    • 5.2.2. Testing Site: Need for rapid diagnostics crucial for immediate patient care in hospitals
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Enteric Disease Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Kits
  • 6.4. Reagents

7. Enteric Disease Testing Market, by Disease Type

  • 7.1. Introduction
  • 7.2. Bacterial
  • 7.3. Parasitic
  • 7.4. Viral

8. Enteric Disease Testing Market, by Diagnostic Techniques

  • 8.1. Introduction
  • 8.2. Immunoassays
  • 8.3. Molecular Diagnostics
  • 8.4. Rapid Diagnostics

9. Enteric Disease Testing Market, by Testing Site

  • 9.1. Introduction
  • 9.2. In-Hospital
  • 9.3. Point-of-Care
  • 9.4. Standalone Laboratories

10. Americas Enteric Disease Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Enteric Disease Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Enteric Disease Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. FDA Clears MeMed BV Direct from Whole Blood
    • 13.3.2. Avacta Acquires European Diagnostic Test Maker
    • 13.3.3. Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. ENTERIC DISEASE TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. ENTERIC DISEASE TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ENTERIC DISEASE TESTING MARKET DYNAMICS
  • FIGURE 7. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. ENTERIC DISEASE TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. ENTERIC DISEASE TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ENTERIC DISEASE TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY KITS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY KITS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REAGENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY CHOLERA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY CHOLERA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY ESCHERICHIA COLI, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY ESCHERICHIA COLI, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY SALMONELLOSIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY SALMONELLOSIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PARASITIC, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PARASITIC, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY VIRAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY VIRAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PCR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PCR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DIPSTICKS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DIPSTICKS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY IN-HOSPITAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY IN-HOSPITAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY POINT-OF-CARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY POINT-OF-CARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY STANDALONE LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY STANDALONE LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 71. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
  • TABLE 72. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
  • TABLE 73. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 74. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 77. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
  • TABLE 80. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
  • TABLE 81. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
  • TABLE 82. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
  • TABLE 83. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 84. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 85. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 86. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 87. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
  • TABLE 88. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
  • TABLE 89. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 90. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 91. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 92. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 93. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
  • TABLE 94. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
  • TABLE 95. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
  • TABLE 96. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
  • TABLE 97. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 98. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 99. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 100. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 101. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
  • TABLE 102. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
  • TABLE 103. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 104. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 105. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 106. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 107. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
  • TABLE 108. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
  • TABLE 109. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
  • TABLE 110. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
  • TABLE 111. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 112. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 113. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 114. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 115. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
  • TABLE 116. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
  • TABLE 117. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 118. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 119. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 120. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 121. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
  • TABLE 122. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
  • TABLE 123. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
  • TABLE 124. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
  • TABLE 125. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 126. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 127. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 128. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 129. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
  • TABLE 130. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
  • TABLE 131. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 132. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 133. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 134. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 135. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
  • TABLE 136. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
  • TABLE 137. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
  • TABLE 138. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
  • TABLE 139. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 140. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 141. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 142. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 143. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
  • TABLE 144. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
  • TABLE 145. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 146. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 163. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 164. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 165. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 166. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 167. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
  • TABLE 168. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
  • TABLE 169. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
  • TABLE 170. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
  • TABLE 171. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 172. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 173. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 174. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 175. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
  • TABLE 176. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
  • TABLE 177. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 178. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 179. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 180. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 181. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
  • TABLE 182. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
  • TABLE 183. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
  • TABLE 184. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
  • TABLE 185. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 186. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 187. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 188. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 189. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
  • TABLE 190. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
  • TABLE 191. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 192. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 193. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 194. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 195. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
  • TABLE 196. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
  • TABLE 197. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
  • TABLE 198. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
  • TABLE 199. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 200. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 201. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 202. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 203. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
  • TABLE 204. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
  • TABLE 205. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 206. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 207. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 208. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 209. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
  • TABLE 210. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
  • TABLE 211. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
  • TABLE 212. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
  • TABLE 213. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 214. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 215. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 216. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 217. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
  • TABLE 218. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
  • TABLE 219. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 220. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 221. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 222. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 223. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
  • TABLE 224. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
  • TABLE 225. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
  • TABLE 226. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
  • TABLE 227. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 228. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 229. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 230. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 231. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
  • TABLE 232. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
  • TABLE 233. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 234. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 235. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 236. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 237. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
  • TABLE 238. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
  • TABLE 239. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
  • TABLE 240. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
  • TABLE 241. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 242. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 243. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 244. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 245. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
  • TABLE 246. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
  • TABLE 247. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 248. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 249. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
  • TABLE 252. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
  • TABLE 253. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
  • TABLE 254. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
  • TABLE 255. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 256. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 257. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 258. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 259. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
  • TABLE 260. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
  • TABLE 261. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 262. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 263. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 264. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 265. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
  • TABLE 266. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
  • TABLE 267. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
  • TABLE 268. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
  • TABLE 269. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 270. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 271. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 272. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 273. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
  • TABLE 274. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
  • TABLE 275. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 276. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 277. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 278. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 279. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
  • TABLE 280. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
  • TABLE 281. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
  • TABLE 282. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
  • TABLE 283. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 284. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 285. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 286. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 287. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
  • TABLE 288. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
  • TABLE 289. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 290. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 291. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 292. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 293. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
  • TABLE 294. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
  • TABLE 295. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
  • TABLE 296. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
  • TABLE 297. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 298. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 299. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 300. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 301. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
  • TABLE 302. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
  • TABLE 303. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 304. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 305. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 306. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 307. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
  • TABLE 308. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
  • TABLE 309. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
  • TABLE 310. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
  • TABLE 311. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 312. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 313. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 314. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 315. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
  • TABLE 316. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
  • TABLE 317. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 318. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 319. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 320. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 321. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
  • TABLE 322. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
  • TABLE 323. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
  • TABLE 324. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
  • TABLE 325. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 326. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 327. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 328. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE